
One scientific development can lead to many more for patients with myeloproliferative neoplasms, a type of rare blood cancer, according to an expert.

Brielle Benyon, Assistant Managing Editor for CURE®, has been with MJH Life Sciences since 2016. She has served as an editor on both CURE and its sister publication, Oncology Nursing News. Brielle is a graduate from The College of New Jersey. Outside of work, she enjoys spending time with family and friends, CrossFit and wishing she had the grace and confidence of her toddler-aged daughter.
Follow Brielle on Twitter @Brielle_Benyon.

One scientific development can lead to many more for patients with myeloproliferative neoplasms, a type of rare blood cancer, according to an expert.

After a patient is diagnosed with a rare disease such as a myeloproliferative neoplasm, learning about their condition and seeking expert clinicians can help put their mind at ease.

Children and young adults often take on more responsibility when their parent is diagnosed with cancer. A recent study surveyed these young carers about their experience.

From actress and journalist Maria Menounos opening up about her pancreatic diagnosis to the Pennsylvania governor signing a bill for free screenings, here’s what’s happening in the oncology space this week.

After surviving a benign brain tumor, actress and journalist Maria Menounos announced a stage 2 pancreatic cancer diagnosis while expecting a baby.

Patients who used a medical beverage during chemotherapy treatment tended to have fewer gastrointestinal side effects and hospital visits, a small study showed.

Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.

While certain gut microbiota may affect how a patient with lymphoma may response to CAR-T cell therapy, far more work is needed to better understand the connection.

We recently asked patients, survivors and caregivers of those with cancer to share an inspiring quote or mantra that helped them through cancer.

Among patients who held ice in their mouth before, during and after chemotherapy, 78% did not experience oral mucositis.

May is National Melanoma and Skin Cancer Awareness Month, so we took a look at some of the top stories about the disease from 2023.

Dr. Naveen Pemmaraju outlines three reasons why he feels that there is “a momentum that’s unmistakable,” in the field of myeloproliferative neoplasms.

From talk show host Jerry Springer’s death to “The Young and the Restless” star announcing a cancer diagnosis, here is what’s happening in the oncology space this week.

Watch Dr. Kenneth H. Shain, from Moffitt Cancer Center, discuss the future of myeloma treatment, including BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

Watch Dr. Surbhi Sidana, from Stanford Medicine, discuss CAR-T cell therapy during the CURE Educated Patient Multiple Myeloma Summit.

We asked the CURE® audience how they coped with insomnia after a cancer diagnosis. Here is what they had to say.

Darovasertib plus Xalkori is showing promise for the treatment of patients with metastatic uveal melanoma, according to results from an ongoing study.

The financial stress from a colorectal cancer diagnosis can negatively impact sleep and pain tolerance in partners of patients with colorectal cancer, recent research showed.

OKN-007 is being evaluated both alone and in combination with chemotherapy for patients with glioma or glioblastoma — both types of brain cancer.

Mayra Andujar Delgado does not shy away from discussing her myelofibrosis diagnosis. In fact, the survivor becomes empowered by sharing her knowledge with others.

From ‘Pokémon’ actor James Carter Cathcart stepping away from the show to undergo cancer treatment to Ahmad Jamal and Otis Redding III dying of cancer, here’s what’s happening in the oncology space this week.

Watch Dr. Ariel F. Grajales-Cruz, from Moffitt Cancer Center, discuss updates in MGUS and smoldering disease during the CURE Educated Patient Multiple Myeloma Summit.

Before being diagnosed with stage 3 ovarian cancer at the age of 34, Jennifer Broxterman was constantly told that she was young and healthy — but the registered dietitian knew that something was off.

Bariatric surgery may reduce the body’s way of absorbing drugs for chronic myeloid leukemia, research showed.

The Food and Drug Administration approved Polivy plus Rituxan, cyclophosphamide, doxorubicin and prednisone for patients with previously untreated diffuse large B-cell lymphoma — marking the first new regimen in nearly two decades for this patient population.

We asked our audience what advancements they hope to see in the oncology space within the next decade or so. Here’s what they had to say.

The FDA granted a priority review to Lonsurf with or without Avastin for the treatment of patients with pretreated metastatic colorectal cancer.

HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.

The Food and Drug Administration granted botensilimab plus balstilimab a Fast Track Designation to treat certain patients with metastatic colorectal cancer.

Omisirge is an umbilical cord blood-based therapy that may prevent infection in patients with blood cancer undergoing stem cell transplant.